A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma

Leuk Lymphoma. 2018 May;59(5):1180-1187. doi: 10.1080/10428194.2017.1369063. Epub 2017 Sep 1.

Abstract

Hodgkin lymphoma (HL) survivors are at increased risk of thyroid cancer (TC). We sought to determine whether increased risks of high-risk pathology or mortality are seen with thyroid cancer after HL (HL-TC) compared with first primary thyroid cancer (TC-1). From the Surveillance, Epidemiology and End Results (SEER) registry, we compared patient and tumor characteristics as well as survival outcomes between HL-TC and TC-1 and fit a multivariable Cox model to assess for a possible association between HL history and overall survival after TC. Among 139,297 TC-1 and 174 HL-TC patients, history of HL was not associated with anaplastic or sarcoma TC. Multivariable analyzes showed that history of HL was not associated with a difference in risk of death after TC (hazard ratio: 0.96, 95% confidence interval: (0.81, 1.13), p = .61). Despite a significantly increased risk of TC among HL survivors, prior HL is not associated with more aggressive pathologic subtypes or worse prognosis.

Keywords: Hodgkin lymphoma; Second malignancy; cancer survivorship; thyroid cancer.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Female
  • Follow-Up Studies
  • Hodgkin Disease / complications*
  • Hodgkin Disease / epidemiology
  • Hodgkin Disease / radiotherapy
  • Humans
  • Male
  • Middle Aged
  • Neoplasms, Second Primary / etiology
  • Neoplasms, Second Primary / mortality*
  • Neoplasms, Second Primary / pathology
  • New York / epidemiology
  • Prognosis
  • Risk Factors
  • SEER Program
  • Survival Rate
  • Survivors / statistics & numerical data*
  • Thyroid Neoplasms / etiology
  • Thyroid Neoplasms / mortality*
  • Thyroid Neoplasms / pathology
  • Young Adult